LU-35138

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLU-35138
Drug Alias NameLU-35138
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin reuptake inhibitorsDopamine D4 receptor antagonists
TargetsDopamine D4 receptorSerotonin transporter
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesH. Lundbeck A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesH. Lundbeck A/S
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A